Skip to content

Thermo Fisher Scientific Collaborates with Taiwan Precision Medication Initiative to Genotype 1 Million Folks in Taiwan

Largest predictive genomics mission exterior of US and Europe goals to extend variety in genomic analysis and enhance well being for Han Chinese language individuals all over the world

CARLSBAD, Calif., September 13, 2022–(BUSINESS WIRE)–Thermo Fisher Scientific companions with the Taiwan Precision Medication Initiative (TPMI) to advance the subsequent part of the large-scale predictive genomics research and help its purpose of genotyping 1 million individuals in Taiwan. TPMI reached the milestone of enrolling greater than 500,000 contributors in July, making it the most important research of its variety exterior of america and Europe.

Launched by Academia Sinica and a community of hospital methods all through the nation in 2019, the predictive genomics mission goals to optimize the way forward for healthcare by enabling clinicians towards establishing future tips to handle sufferers at excessive threat for severe ailments reminiscent of most cancers, cardiovascular, neurodegenerative and different issues in addition to present personalised drug prescription primarily based on pharmacogenetic elements.

TPMI initially collaborated with Thermo Fisher to design a customized genotyping analysis array for figuring out genetic elements which will enhance the danger of sure ailments. Within the subsequent part of the mission, TPMI will work with Thermo Fisher to optimize the Axiom genotyping platform* with the goal of translating the outcomes to medical use and increasing the event of illness threat prediction algorithms for not less than 20 frequent ailments related to Han Chinese language individuals, roughly 18% of the worldwide inhabitants[1].

“The healthcare neighborhood is working towards offering the medical and financial worth of predictive genomics to lower threat of illness and enhance well being, and initiatives such because the Taiwan Precision Medication Initiative promise to assist distribute the advantages of precision medication extra broadly and equitably,” mentioned Chad Carter, vp and normal supervisor of microarray genetic options at Thermo Fisher Scientific. “We’re proud to proceed the Utilized Biosystems legacy of supporting large-scale genomic analysis initiatives by becoming a member of TPMI on this vital initiative.”

The Axiom customized array developed for TPMI comprises greater than 700,000 genetic markers chosen to seize variants of curiosity. Preliminary TPMI evaluation revealed 83 probably clinically related genes related to illness threat or drug reactions.

“Thermo Fisher’s Axiom customized genotyping platform offers best-in-class modular content material, skilled customization capabilities, and a cheap and scalable technique for analyzing biomarkers of curiosity within the Han Chinese language inhabitants,” mentioned Dr. Pui-Yan Kwok, director of the Institute of Biomedical Science on the Academia Sinica and chief of TPMI. “By figuring out genetic elements related to illness threat, we will help set up a sustainable precision well being ecosystem to enhance well being, cut back medical prices and gas revolutionary analysis in Taiwan.”

Thermo Fisher at the moment helps a number of large-scale inhabitants research globally, together with UK Biobank, FinnGen Precision Medication Examine, Qatar Genome Program and the US Division of Veterans Affairs’ Million Veteran Program (MVP). Every of those initiatives leverages the corporate’s Utilized Biosystems Axiom genotyping arrays and customization companies, which have helped to drive predictive genomic research for greater than a decade.

For extra data on Taiwan Precision Medication Initiative, go to https://tpmi.ibms.sinica.edu.tw/www/en/.

For extra data on genotyping applied sciences from Thermo Fisher, go to www.thermofisher.com/genotyping.

*For analysis use solely. Not to be used in diagnostic procedures.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world chief in serving science, with annual income of roughly $40 billion. Our Mission is to allow our clients to make the world more healthy, cleaner and safer. Whether or not our clients are accelerating life sciences analysis, fixing advanced analytical challenges, rising productiveness of their laboratories, bettering affected person well being by diagnostics or the event and manufacture of life-changing therapies, we’re right here to help them. Our world workforce delivers an unequalled mixture of revolutionary applied sciences, buying comfort and pharmaceutical companies by our industry-leading manufacturers, together with Thermo Scientific, Utilized Biosystems, Invitrogen, Fisher Scientific, Unity Lab Companies, Patheon and PPD.

For extra data, please go to www.thermofisher.com

[1] Wikipedia | Han Chinese language. Accessed August 15, 2022

View supply model on businesswire.com: https://www.businesswire.com/information/residence/20220913005377/en/

contacts

Half:

Mauricio Minotta
Telephone: 760-805-5266
E-mail: mauricio.minotta@thermofisher.com

Jennifer Heady
Telephone: 413-237-5141
E-mail: jheady@greenough.biz

Leave a Reply

Your email address will not be published.